Early amniotomy and early oxytocin for prevention of, or therapy for, delay in first stage spontaneous labour compared with routine care

Département d'Obstétrique-Gynécologie, Université de Montréal, Hôpital, Canada.
Cochrane database of systematic reviews (Online) (Impact Factor: 5.94). 01/2012; 9(2):CD006794. DOI: 10.1002/14651858.CD006794.pub3
Source: PubMed

ABSTRACT Caesarean section rates are over 20% in many developed countries. The main diagnosis contributing to the high rate in nulliparae is dystocia or prolonged labour. The present review assesses the effects of a policy of early amniotomy with early oxytocin administration for the prevention of, or the therapy for, delay in labour progress.
To estimate the effects of early augmentation with amniotomy and oxytocin for prevention of, or therapy for, delay in labour progress on the caesarean birth rate and on indicators of maternal and neonatal morbidity.
We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (15 February 2012), MEDLINE (1966 to 15 February 2012), EMBASE (1980 to 15 February 2012), CINAHL (1982 to 15 February 2012), MIDIRS (1985 to February 2012) and contacted authors for data from unpublished trials.
Randomized and quasi-randomized controlled trials that compared oxytocin and amniotomy with expectant management.
Three review authors extracted data independently. We stratified the analyses into 'Prevention Trials' and 'Therapy Trials' according to the status of the woman at the time of randomization. Participants in the 'Prevention Trials' were unselected women, without slow progress in labour, who were randomized to a policy of early augmentation or to routine care. In 'Treatment Trials' women were eligible if they had an established delay in labour progress.
For this update, we have included a further two new clinical trials. This updated review includes 14 trials, randomizing a total of 8033 women. The unstratified analysis found early intervention with amniotomy and oxytocin to be associated with a modest reduction in the risk of caesarean section; however, the confidence interval (CI) included the null effect (risk ratio (RR) 0.89; 95% CI 0.79 to 1.01; 14 trials; 8033 women). In prevention trials, early augmentation was associated with a modest reduction in the number of caesarean births (RR 0.87; 95% CI 0.77 to 0.99; 11 trials; 7753). A policy of early amniotomy and early oxytocin was associated with a shortened duration of labour (average mean difference (MD) - 1.28 hours; 95% CI -1.97 to -0.59; eight trials; 4816 women). Sensitivity analyses excluding four trials with a full package of active management did not substantially affect the point estimate for risk of caesarean section (RR 0.87; 95% CI 0.73 to 1.05; 10 trials; 5165 women). We found no other significant effects for the other indicators of maternal or neonatal morbidity.
In prevention trials, early intervention with amniotomy and oxytocin appears to be associated with a modest reduction in the rate of caesarean section over standard care.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Human labour, both at term and preterm, is preceded by NF-κB-mediated inflammatory activation within the uterus, leading to myometrial activation, fetal membrane remodelling and cervical ripening. The stimuli triggering inflammatory activation in normal human parturition are not fully understood. We show that the neurohypophyseal peptide, oxytocin (OT), activates NF-κB and stimulates downstream inflammatory pathways in human gestational tissues. OT stimulation (1 pM–100 nM) specifically via its receptor (OTR) in human myometrial and amnion primary cells led to MAPK and NF-κB activation within 15 min and maximal p65-subunit nuclear translocation within 30 min. Both in human myometrium and amnion, OT-induced activation of the canonical NF-κB pathway upregulated key inflammatory labour-associated genes including IL-8, CCL5, IL-6 and COX-2. IKKβ inhibition (TPCA1; 10 µM) suppressed OT-induced NF-κB-p65 phosphorylation, whereas p65-siRNA knockdown reduced basal and OT-induced COX-2 levels in myometrium and amnion. In both gestational tissues, MEK1/2 (U0126; 10 µM) or p38 inhibition (SB203580; 10 µM) suppressed OT-induced COX-2 expression, but OT-induced p65-phosphorylation was only inhibited in amnion, suggesting OT activation of NF-κB in amnion is MAPK-dependent. Our data provide new insight into the OT/OTR system in human parturition and suggest that its therapeutic modulation could be a strategy for regulating both contractile and inflammatory pathways in the clinical context of term/preterm labour.
    Molecular and Cellular Endocrinology 11/2014; 403. DOI:10.1016/j.mce.2014.11.008 · 4.24 Impact Factor
  • Source
    Cadernos de Saúde Pública 01/2014; 30:S17-S32. DOI:10.1590/0102-311X00151513 · 0.89 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: “Normal” labor has been surprisingly little studied in the past 60 years even though it is a central axis in obstetrics. Standards were proposed 60 years ago by Emmanuel Friedman and adopted by many countries to become then, driven from Dublin school, the conditions allowing the management of labor: rupture of membranes and oxytocin with, in case of failure for dynamic dystocia, cesarean. Recent data have suggested that labor duration had changed since the 1960s. Changes in women's characteristics and in obstetric practice especially with the widespread use of oxytocin and realization of epidural may have an impact on labor duration. Current studies suggest that it may be possible to authorize longer labor duration without significant increase in maternal or neonatal morbidity. However, it is premature to change practices following the latest American recommendations without prior studies.
    Gynécologie Obstétrique & Fertilité 03/2015; 43(4). DOI:10.1016/j.gyobfe.2015.02.016 · 0.58 Impact Factor

Full-text (2 Sources)

Available from
May 31, 2014